Safety and efficacy of sacubitril/valsartan vs. benazepril administered as initial treatment for STEMI patients with mid-range ejection fraction: a propensity score matching analysis - Top-Institutions - MDSpire

Safety and efficacy of sacubitril/valsartan vs. benazepril administered as initial treatment for STEMI patients with mid-range ejection fraction: a propensity score matching analysis

  • By

  • Yanbo Wang

  • Lifang Su

  • Qing Zhou

  • Jia Tian

  • Wei Zhi

  • Yang Fu

  • Qing Wang

  • Yunfa Jiang

  • Xinshun Gu

  • May 28, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Second Hospital of Hebei Medical University
    Second Hospital of Hebei Medical University

    Shijiazhuang, Hebei

    Key Differentiators

    • Cardiology

  • #2

    Medical University of Vienna
    Medical University of Vienna

    Vienna, Vienna

    Key Differentiators

    • Cardiology

  • #3

    Italian academic hospitals
    Italian academic hospitals

    Italy, N/A

    Key Differentiators

    • Cardiology

  • #4

    Netherlands Heart Registration
    Netherlands Heart Registration

    Netherlands, N/A

    Key Differentiators

    • Cardiology

  • #5

    Medical Research Ethics Committees United
    Medical Research Ethics Committees United

    N/A, N/A

    Key Differentiators

    • Cardiology

Original Source(s)

Safety and efficacy of sacubitril/valsartan vs. benazepril administered as initial treatment for STEMI patients with mid-range ejection fraction: a propensity score matching analysis

  • by Yanbo Wang, Lifang Su, Qing Zhou, Jia Tian, Wei Zhi, Yang Fu, Qing Wang, Yunfa Jiang, Xinshun Gu

  • May 28, 2026

Related Content

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

Designing and evaluating large language model-enabled clinical decision support for heart failure: a modular and risk-tiered framework

Hereditary transthyretin amyloid cardiomyopathy caused by the rare TTR p.Ser43Asn variant in an Asian family: a case report